Marshall Wace
INO icon

Marshall Wace’s Inovio Pharmaceuticals INO Stock Holding History

Marshall Wace’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.9K Sell
13,187
-69,144
-84% -$114K ﹤0.01% 3044
2025
Q4 		$143K Buy
+82,331
New +$181K ﹤0.01% 2660
2024
Q2 		– Sell
-51,983
Closed -$722K – 2730
2024
Q1 		$722K Buy
+51,983
New +$449K ﹤0.01% 1786
2021
Q2 		– Sell
-65,401
Closed -$7.28M – 2839
2021
Q1 		$7.28M Buy
+65,401
New +$8.6M 0.03% 625

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace's INO Position: Q1 2026 in Review

Marshall Wace reduced its Inovio Pharmaceuticals (INO) stake by 84% in Q1 2026, selling an estimated $114K and leaving 13,187 shares worth $22.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3044.

Marshall Wace first reported a position in INO in Q1 2021 and has held it in 4 quarters since. The position peaked at $7.28M in Q1 2021. 100 funds tracked by Wall St. Rank hold INO as of Q1 2026.

  • Marshall Wace held 13,187 shares of Inovio Pharmaceuticals worth $22.9K as of Q1 2026.
  • Marshall Wace sold 69,144 Inovio Pharmaceuticals shares in Q1 2026, an estimated $114K.
  • Inovio Pharmaceuticals made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #3044 holding.
  • Marshall Wace first reported a position in Inovio Pharmaceuticals in Q1 2021 and has held it in 4 quarters since.
  • Marshall Wace's Inovio Pharmaceuticals position peaked at $7.28M in Q1 2021.
  • 100 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.